Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linjun Hou

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Genetics|March 3, 2020
Phylogenetic Tree Inference: A Top-Down Approach to Track Tumor EvolutionPin Wu, Linjun Hou, Yingdong Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2024
Switch of ELF3 and ATF4 transcriptional axis programs the amino acid insufficiency-linked epithelial-to-mesenchymal transitionJianxiang Lin, Linjun Hou, Xin Zhao, et al.
Cell Death & Disease|February 16, 2022
Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancerLiping Chu, Yuxiu Qu, Yang An, et al.
Development (Cambridge, England)|February 24, 2025
The KMT2 complex protein ASH2L is required for meiotic prophase progression but dispensable for mitosis in differentiated spermatogoniaZhen Lin, Bowen Rong, Meixia Wu, et al.
The Journal of Biological Chemistry|October 27, 2019
Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-cateninYuetong Wang, Jian Cao, Weiwei Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2019
CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonistsFang Liu, Wenyan Jiang, Yi Sui, et al.
Elife|May 13, 2022
FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cellsYanchun Zhang, Xuexue Xiong, Qi Zhu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Genetics|March 3, 2020
Phylogenetic Tree Inference: A Top-Down Approach to Track Tumor EvolutionPin Wu, Linjun Hou, Yingdong Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2024
Switch of ELF3 and ATF4 transcriptional axis programs the amino acid insufficiency-linked epithelial-to-mesenchymal transitionJianxiang Lin, Linjun Hou, Xin Zhao, et al.
Cell Death & Disease|February 16, 2022
Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancerLiping Chu, Yuxiu Qu, Yang An, et al.
Development (Cambridge, England)|February 24, 2025
The KMT2 complex protein ASH2L is required for meiotic prophase progression but dispensable for mitosis in differentiated spermatogoniaZhen Lin, Bowen Rong, Meixia Wu, et al.
The Journal of Biological Chemistry|October 27, 2019
Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-cateninYuetong Wang, Jian Cao, Weiwei Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2019
CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonistsFang Liu, Wenyan Jiang, Yi Sui, et al.
Elife|May 13, 2022
FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cellsYanchun Zhang, Xuexue Xiong, Qi Zhu, et al.
Pageof 1